IP Library Granted Patent US 10,988,751
Granted Patent B2
US 10,988,751 · App. 16/481,585 · Granted Apr 27, 2021

Diphosphomevalonate decarboxylase variant and method for manufacturing olefin compound using same

Inventors: Ryoko Orishimo (Wako, JP); Tomokazu Shirai (Wako, JP); Kazuhiro Takahashi (Tokyo, JP); Misao Hiza (Hiratsuka, JP); Yusuke Tanabe (Hiratsuka, JP)
Assignees: RIKEN; ZEON CORPORATION; THE YOKOHAMA RUBBER CO., LTD.
C12N9/88C12P5/007C12P5/02C12Y401/01033
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,988,751
App. No.
16/481,585
Granted
Apr 27, 2021
Kind
B2
Abstract

A method enables olefin compound production with a high productivity, and an enzyme is used in the method. Mutations involving amino acid substitution are introduced into various sites of diphosphomevalonate decarboxylase (MVD) to prepare multiple MVD variants. Then, these variants are evaluated in terms of catalytic activity for producing an olefin compound such as isoprene, and have found as a result that the catalytic activity is improved when serine at position 153 and threonine at position 209 are each substituted with a different amino acid. In addition, the catalytic activity of the variants is further improved when glycine at position 152 is further substituted with a different amino acid.

Claims (16)

1. A method for producing isoprene or isobutene, the method comprising:

reacting ATP and a substrate compound in the presence of a diphosphomevalonate decarboxylase to produce isoprene or isobutene,

wherein:

the diphosphomevalonate decarboxylase is a protein in which:

serine at position 153 of SEQ ID NO: 2 or serine corresponding to the position is mutated to aspartic acid or glutamic acid,

threonine at position 209 of SEQ ID NO: 2 or threonine corresponding to the position is mutated to aspartic acid, and

the amino acid sequence consists of the amino acid sequence of SEQ ID NO: 2 or an amino acid sequence in which no more than 40 amino acid residues of the amino acid sequence of SEQ ID NO: 2 are substituted, deleted, added, and/or inserted other than at positions 153 and 209,

and

when the method produces isoprene, the substrate compound is 3-hydroxy-3-methylpent-4-enoate and

when the method produces isobutene, the substrate compound is (β-hydroxyisovaleric acid.

2. The production method according to claim 1 , wherein reacting ATP and the substrate compound in the presence of the diphosphomevalonate decarboxylase is performed by culturing a host cell comprising:

a DNA encoding the diphosphomevalonate decarboxylase, or

a vector comprising the DNA.

3. The production method according to claim 1 , wherein in the diphosphomevalonate decarboxylase, glycine at position 152 of SEQ ID NO: 2 or glycine corresponding to the position is mutated to a different amino acid.

4. The production method according to claim 3 , wherein the different amino acid mutated from the glycine at position 152 of SEQ ID NO: 2 or the glycine corresponding to the position is leucine.

5. The production method according to claim 1 , wherein the method produces isoprene.

Assignments (2)
CHANGE OF ADDRESS FOR ASSIGNEE Recorded Nov 18, 2023
From: THE YOKOHAMA RUBBER CO., LTD.
To: THE YOKOHAMA RUBBER CO., LTD.
Reel/Frame 065626/0740 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2019
From: ORISHIMO, RYOKO; SHIRAI, TOMOKAZU; TAKAHASHI, KAZUHIRO; HIZA, MISAO; TANABE, YUSUKE
To: RIKEN; ZEON CORPORATION; THE YOKOHAMA RUBBER CO., LTD.
Reel/Frame 050462/0919 →